Skip to main content
logo
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.570
+0.010 (0.39%)
At close: Apr 2, 2026, 4:00 PM EDT
2.409
-0.161 (-6.28%)
After-hours: Apr 2, 2026, 7:53 PM EDT

Genelux Revenue

In the year 2025, Genelux had annual revenue of $8.00K. Genelux had revenue of $8.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
14,254.66
Revenue / Employee
$308
Employees
26
Market Cap
114.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20258.00K--
Dec 31, 20248.00K-162.00K-95.29%
Dec 31, 2023170.00K-10.90M-98.46%
Dec 31, 202211.07M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sangamo Therapeutics39.55M
Innate Pharma10.57M
Equillium4.39M
Cardiff Oncology593.00K
NeOnc Technologies Holdings39.99K
Revenue Rankings

GNLX News

More News